Bell Investment Advisors’s DICE Therapeutics, Inc. Common Stock DICE Stock Holding History
Bought
Maintained
Sold
Bell Investment Advisors's DICE Position: Q3 2023 in Review
Bell Investment Advisors sold out of DICE Therapeutics, Inc. Common Stock (DICE) in Q3 2023, closing a stake of 15 shares — an estimated $697 sold.
Bell Investment Advisors first reported a position in DICE in Q2 2023 and held it in 1 quarter. The position peaked at $697 in Q2 2023. 0 funds tracked by Wall St. Rank hold DICE as of Q3 2023.
- Bell Investment Advisors reported no remaining DICE Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
- Bell Investment Advisors sold 15 DICE Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $697.
- Bell Investment Advisors first reported a position in DICE Therapeutics, Inc. Common Stock in Q2 2023 and held it in 1 quarter.
- Bell Investment Advisors's DICE Therapeutics, Inc. Common Stock position peaked at $697 in Q2 2023.
- 0 funds tracked by Wall St. Rank held DICE Therapeutics, Inc. Common Stock as of Q3 2023.
Based on Bell Investment Advisors's 13F filing for Q3 2023, filed 8 Nov 2023.